Investors
Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.
Financial Reports & Accounts
| Date | Title | Document |
|---|---|---|
| 22/05/23 | Annual Report 2022 | Download |
| 14/09/22 | Interim Report 2022 | Download |
| 24/05/22 | Annual Report 2021 | Download |
| 17/09/21 | Interim Report 2021 | Download |
| 21/05/21 | Annual Report 2020 | Download |
| 14/09/20 | Interim Report 2020 | Download |
| 30/06/20 | Annual Report 2019 | Download |
| 30/09/19 | Interim Report 2019 | Download |
| 24/05/19 | Annual Report 2018 | Download |
| 27/09/18 | Interim Report 2018 | Download |
| 01/06/17 | Annual Report 2017 | Download |
| 13/10/17 | Interim Report 2017 | Download |
| 10/04/17 | Annual Report 2016 | Download |
| 22/09/16 | Interim Report 2016 | Download |
| 13/04/16 | Annual Report 2015 | Download |
| 14/09/15 | Interim Report 2015 | Download |
| 15/05/15 | Annual Report 2014 | Download |
| 24/05/22 | Annual Report 2021 | Download |